Alan B. Lancz & Associates, Inc. Sanofi Transaction History
Alan B. Lancz & Associates, Inc.
- $108 Million
- Q3 2024
A detailed history of Alan B. Lancz & Associates, Inc. transactions in Sanofi stock. As of the latest transaction made, Alan B. Lancz & Associates, Inc. holds 6,050 shares of SNY stock, worth $319,742. This represents 0.32% of its overall portfolio holdings.
Number of Shares
6,050
Previous 6,300
3.97%
Holding current value
$319,742
Previous $305,000
14.1%
% of portfolio
0.32%
Previous 0.3%
Shares
9 transactions
Others Institutions Holding SNY
# of Institutions
809Shares Held
253MCall Options Held
2.6MPut Options Held
1.64M-
Dodge & Cox San Francisco, CA77.1MShares$4.08 Billion2.36% of portfolio
-
Morgan Stanley New York, NY14.7MShares$779 Million0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa13.6MShares$719 Million0.29% of portfolio
-
Bank Of America Corp Charlotte, NC11.2MShares$592 Million0.05% of portfolio
-
Invesco Ltd. Atlanta, GA10.5MShares$556 Million0.11% of portfolio
About Sanofi
- Ticker SNY
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,508,100,096
- Market Cap $133B
- Description
- Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...